Education
About Us
Working with TipRanks
Follow Us
Hansoh Pharmaceutical Group Company Limited (HK:3692)
:3692
RESEARCH TOOLSreports
Total Valuation
Hansoh Pharmaceutical Group Company Limited has a market cap or net worth of HK$131.18B. The enterprise value is HK$77.81B.
Market CapHK$131.18B
Enterprise ValueHK$77.81B
Share Statistics
Hansoh Pharmaceutical Group Company Limited has 5,935,650,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,935,650,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Hansoh Pharmaceutical Group Company Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee1.12M
Profits Per Employee364.61K
Employee Count8,989
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Hansoh Pharmaceutical Group Company Limited is ―. Hansoh Pharmaceutical Group Company Limited’s PEG ratio is ―.
PE Ratio―
PS Ratio7.43
PB Ratio―
Price to Fair Value―
Price to FCF―
Price to Operating Cash Flow―
PEG Ratio―
Income Statement
In the last 12 months, Hansoh Pharmaceutical Group Company Limited had revenue of 10.10B and earned 3.28B in profits. Earnings per share was 0.52.
Revenue10.10B
Gross Profit9.07B
Operating Income2.84B
Pretax Income3.77B
Net Income3.28B
EBITDA4.20B
Earnings Per Share (EPS)0.52
Cash Flow
In the last 12 months, operating cash flow was 4.65B and capital expenditures -228.81M, giving a free cash flow of 4.42B billion.
Operating Cash Flow4.65B
Free Cash Flow4.42B
Free Cash Flow per Share0.75
Dividends & Yields
Hansoh Pharmaceutical Group Company Limited pays an annual dividend of HK$0.135, resulting in a dividend yield of 1.55%
Dividend Per ShareHK$0.135
Dividend Yield1.55%
Payout Ratio18.05%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.83
52-Week Price Change37.78%
50-Day Moving Average20.06
200-Day Moving Average18.70
Relative Strength Index (RSI)54.12
Average Volume (3m)12.77M
Important Dates
Hansoh Pharmaceutical Group Company Limited upcoming earnings date is Aug 27, 2025, TBA Not Confirmed.
Last Earnings DateMar 21, 2025
Next Earnings DateAug 27, 2025
Ex-Dividend DateJul 03, 2025
Financial Position
Hansoh Pharmaceutical Group Company Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Hansoh Pharmaceutical Group Company Limited has paid 488.65M in taxes.
Income Tax488.65M
Effective Tax Rate―
Enterprise Valuation
Hansoh Pharmaceutical Group Company Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Hansoh Pharmaceutical Group Company Limited has HK$23.50B in cash and marketable securities with ¥4.30B in debt, giving a net cash position of -HK$23.38B billion.
Cash & Marketable SecuritiesHK$23.50B
Total Debt¥4.30B
Net Cash-HK$23.38B
Net Cash Per Share-HK$3.94
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Hansoh Pharmaceutical Group Company Limited is HK$26.23, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price TargetHK$26.23
Price Target Upside18.69% Upside
Analyst ConsensusStrong Buy
Analyst Count4
Revenue Growth Forecast19.29%
EPS Growth Forecast31.42%